Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?
Movement Disorders Clinical Practice, 2021 The relative importance of antimuscarinic anticholinergic medications for Parkinson's disease (PD) declined after the introduction of levodopa, such that anticholinergic medications are now much more likely to be prescribed for clinical indications other
M. Barrett +5 more
semanticscholar +1 more source
Anticholinergic Medication and Caries Status Predict Xerostomia under 65
Dentistry Journal, 2023 The use of anticholinergic medications is increasing in younger ages, yet information about xerostomia, the most common anticholinergic side effect, is limited.
Hui Ling Cheah +4 more
doaj +1 more source
Results of medications and bladder managements of vesicoureteral reflux in patients with a spinal cord lesion [PDF]
Songklanakarin Journal of Science and Technology (SJST), 2020 The purpose of the present study was to study the outcome of medical treatments and methods used to treat vesicoureteral reflux (VUR) in patients with spinal cord lesions.
Nalinee Tipsri +3 more
doaj +1 more source
El reto del envejecimiento y la complejidad farmacoterapéutica en el paciente VIH+ [PDF]
, 2018 Objective: To describe the current knowledge and management of aging and pharmacotherapeutic complexity in HIV + patients. Method: A review of literature was carried out, including articles, originals or reviews, published in English or Spanish, from ...
Abdel Kader Martín, Laila +3 more
core +3 more sources
Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review
Therapeutic Advances in Drug Safety, 2021 Introduction: Several adverse outcomes have been associated with anticholinergic burden (ACB), and these risks increase with age. Several approaches to measuring this burden are available but, to date, no comparison of their prognostic abilities has been
Carrie Stewart +5 more
semanticscholar +1 more source
BMJ Open, 2021 Objectives The aims of our study were to examine the anticholinergic drug use and to assess the association between anticholinergic burden and cognitive function in the multimorbid elderly patients of the MultiCare cohort.Setting MultiCare was conducted ...
Hans-Helmut König +15 more
doaj +1 more source
Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale [PDF]
, 2012 Background Drugs with anticholinergic effects are associated with adverse events such as delirium and falls as well as cognitive decline and loss of independence.
CORRAO, Salvatore +12 more
core +1 more source
Neurourology and Urodynamics, 2020 Long‐term treatment with anticholinergic agents may increase the risk of cognitive impairment or dementia. This systematic literature review and meta‐analysis aimed to assess the impact of ≥3 months of exposure to anticholinergics as a class on the risk ...
R. Dmochowski +9 more
semanticscholar +1 more source
Saudi Pharmaceutical Journal, 2023 Background: Geriatric cancer patients are susceptible to adverse drug events due to the complexity of their chemotherapy regimens and collateral treatments for their comorbid conditions. Prescribing medications with anticholinergic burden characteristics
Ahmad Al-Azayzih +5 more
doaj +1 more source
Analysis of iatrogenic risk related to anticholinergic effects using two scales in acute geriatric inpatient unit [PDF]
, 2012 Anticholinergic medications are responsible for most frequent adverse drug effects. Two scales have been elaborated as tools for prescribers: the Anticholinergic Drug Scale (ADS) of Carnahan et al., and the Anticholinergic Risk Scale (ARS) of Rudolph et ...
A. Gouraud-Tanguy +6 more
core +3 more sources